Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors
An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors....
Saved in:
Published in | Molecules (Basel, Switzerland) Vol. 23; no. 3; p. 679 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
17.03.2018
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme. |
---|---|
AbstractList | An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme. An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC 50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme. An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme. An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme.An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is one of the DNA repair system enzymes involved in the removal of DNA damages caused by topoisomerase I inhibitors. Thus, reducing the activity of Tdp1 can increase the effectiveness of currently used anticancer drugs. We describe here a new class of semisynthetic small molecule Tdp1 inhibitors based on the bile acid scaffold that were originally identified by virtual screening. The influence of functional groups of bile acids (hydroxy and acetoxy groups in the steroid framework and amide fragment in the side chain) on inhibitory activity was investigated. In vitro studies demonstrate the ability of the semisynthetic derivatives to effectively inhibit Tdp1 with IC50 up to 0.29 µM. Furthermore, an excellent fit is realized for the ligands when docked into the active site of the Tdp1 enzyme. |
Author | Chand, Raina Popadyuk, Irina Lavrik, Olga Reynisson, Jóhannes Salakhutdinov, Nariman Salomatina, Oksana Zakharova, Olga Komarova, Nina Arabshahi, H. Zakharenko, Alexandra Volcho, Konstantin Fadeev, Dmitriy |
AuthorAffiliation | 1 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SB RAS, acad. Lavrentjev ave. 9, Novosibirsk 630090, Russia; ana@nioch.nsc.ru (O.V.S.); popadyuk@nioch.nsc.ru (I.I.P.); dsf@nioch.nsc.ru (D.S.F.); komar@nioch.nsc.ru (N.I.K); anvar@nioch.nsc.ru (N.F.S.) 3 School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand; j.reynisson@auckland.ac.nz (J.R.); j.arabshahi@auckland.ac.nz (H.J.A.); rcha387@aucklanduni.ac.nz (R.C.) 4 Novosibirsk State University, Pirogova str. 2, Novosibirsk 630090, Russia 2 Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SB RAS, acad. Lavrentjev ave. 8, Novosibirsk 630090, Russia; sashaz@niboch.nsc.ru (A.L.Z); isar@niboch.nsc.ru (O.D.Z.); lavrik@niboch.nsc.ru (O.I.L.) |
AuthorAffiliation_xml | – name: 1 N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, SB RAS, acad. Lavrentjev ave. 9, Novosibirsk 630090, Russia; ana@nioch.nsc.ru (O.V.S.); popadyuk@nioch.nsc.ru (I.I.P.); dsf@nioch.nsc.ru (D.S.F.); komar@nioch.nsc.ru (N.I.K); anvar@nioch.nsc.ru (N.F.S.) – name: 2 Novosibirsk Institute of Chemical Biology and Fundamental Medicine, SB RAS, acad. Lavrentjev ave. 8, Novosibirsk 630090, Russia; sashaz@niboch.nsc.ru (A.L.Z); isar@niboch.nsc.ru (O.D.Z.); lavrik@niboch.nsc.ru (O.I.L.) – name: 3 School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand; j.reynisson@auckland.ac.nz (J.R.); j.arabshahi@auckland.ac.nz (H.J.A.); rcha387@aucklanduni.ac.nz (R.C.) – name: 4 Novosibirsk State University, Pirogova str. 2, Novosibirsk 630090, Russia |
Author_xml | – sequence: 1 givenname: Oksana surname: Salomatina fullname: Salomatina, Oksana – sequence: 2 givenname: Irina surname: Popadyuk fullname: Popadyuk, Irina – sequence: 3 givenname: Alexandra surname: Zakharenko fullname: Zakharenko, Alexandra – sequence: 4 givenname: Olga surname: Zakharova fullname: Zakharova, Olga – sequence: 5 givenname: Dmitriy surname: Fadeev fullname: Fadeev, Dmitriy – sequence: 6 givenname: Nina surname: Komarova fullname: Komarova, Nina – sequence: 7 givenname: Jóhannes orcidid: 0000-0003-4174-9512 surname: Reynisson fullname: Reynisson, Jóhannes – sequence: 8 givenname: H. surname: Arabshahi fullname: Arabshahi, H. – sequence: 9 givenname: Raina surname: Chand fullname: Chand, Raina – sequence: 10 givenname: Konstantin orcidid: 0000-0002-4083-9324 surname: Volcho fullname: Volcho, Konstantin – sequence: 11 givenname: Nariman surname: Salakhutdinov fullname: Salakhutdinov, Nariman – sequence: 12 givenname: Olga surname: Lavrik fullname: Lavrik, Olga |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29562592$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kk1v1DAQhiNURD_gB3BBlrhwCYy_4s0FaWkLrFQVJMrZcpxJ45U3Xuxkpf33OGyL2iJOtmbeeTQz75wWR0MYsCheU3jPeQ0fNsGjnTwmxoFDpepnxQkVDEoOoj568D8uTlNaAzAqqHxRHLNaVkzW7KTA67BDT37gxqX9MPY4OksuMLqdGd0OEwkd-eQ8kqV1bSImkcuuQzvnyM0-hrT35cX1knzvQ9r2oXWYRowmIaFkNfSucWOI6WXxvDM-4au796z4-fny5vxrefXty-p8eVVaUfOxtFDVChYNA-SoKuBdI1pacwBVVw2VnUDbSQHMGiGllQxb2kKNvBLQKaH4WbE6cNtg1nob3cbEvQ7G6T-BEG-1iXlCj7oTVcV5w3i1YMI2tJFolGkRsbWcC5lZHw-s7dRschCHMRr_CPo4M7he34adroAqxWfAuztADL-mvBedd2zRezNgmJJmWQfZBzVL3z6RrsMUh7wqzSgspKQLKrLqzcOO_rZy72YWqIPAZmNSxE5bN2Yfw9yg85qCnu9G_3M3uZI-qbyH_7_mN-WVyKU |
CitedBy_id | crossref_primary_10_1002_med_21587 crossref_primary_10_1007_s40487_021_00158_0 crossref_primary_10_1016_j_ejmech_2018_10_055 crossref_primary_10_1134_S1068162019060104 crossref_primary_10_3390_molecules26071945 crossref_primary_10_1016_j_jpcs_2023_111681 crossref_primary_10_3390_molecules25153496 crossref_primary_10_3390_ijms21010126 crossref_primary_10_3390_app9132767 crossref_primary_10_1134_S0026893321020060 crossref_primary_10_1016_j_pharmthera_2019_107396 crossref_primary_10_3390_molecules29030581 crossref_primary_10_1016_j_steroids_2020_108771 crossref_primary_10_3390_molecules24203711 crossref_primary_10_3390_ijms24065781 crossref_primary_10_3390_molecules24030381 crossref_primary_10_3390_molecules23102468 crossref_primary_10_3390_ijms22041780 crossref_primary_10_3390_s21144832 crossref_primary_10_3390_ijms21197162 crossref_primary_10_2174_1570180816666181220121042 crossref_primary_10_3390_molecules27010072 crossref_primary_10_1016_j_bmc_2019_115234 |
Cites_doi | 10.3109/03602532.2014.971957 10.1016/j.bioorg.2017.12.005 10.2174/092986711796957266 10.1038/nrc1977 10.1038/sj.emboj.7601885 10.1073/pnas.211429198 10.1016/j.mrfmmm.2015.09.003 10.1016/j.bmc.2015.03.020 10.1016/j.chembiol.2010.04.012 10.1002/minf.201200103 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO;2-W 10.1093/nar/gkt1260 10.2174/092986710790979971 10.1517/13543776.2011.604314 10.1021/jm300335n 10.1158/1078-0432.CCR-16-1193 10.1074/jbc.M111.333963 10.1016/j.dnarep.2009.02.002 10.1070/RCR4683 10.1038/nsb1203-980 10.1021/acs.jmedchem.5b00136 10.3390/molecules22101710 10.1021/acs.jmedchem.6b01565 10.1016/j.bmc.2016.09.016 10.1016/S0022-2836(02)01154-3 10.1021/ci800298z 10.1006/jmbi.1996.0897 10.1146/annurev.biochem.72.121801.161712 10.1002/prot.20588 10.1023/A:1007996124545 10.1016/0022-1759(83)90303-4 10.1016/j.febslet.2011.01.032 10.3390/molecules19033761 10.7717/peerj.3933 10.1016/j.bmc.2016.09.045 10.1007/s00280-003-0717-6 10.1093/nar/gkm463 10.1038/emboj.2009.302 10.3390/12082106 10.1016/S1074-5521(03)00021-8 10.1194/jlr.R049437 10.1038/nature08444 10.1074/jbc.M405042200 10.1007/s40262-017-0587-4 10.1093/nar/gkx1219 10.1021/jm901061s 10.2174/187152008784220357 10.1021/ja00467a001 10.1038/sj.emboj.7601869 10.1016/j.ejmech.2014.07.080 10.1021/acs.jnatprod.6b00979 10.1093/nar/28.1.235 |
ContentType | Journal Article |
Copyright | 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2018 by the authors. 2018 |
Copyright_xml | – notice: 2018. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2018 by the authors. 2018 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/molecules23030679 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database (ProQuest) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
ExternalDocumentID | oai_doaj_org_article_f46633b236824cb1b5ea7adeeedc3345 PMC6017735 29562592 10_3390_molecules23030679 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 123 2WC 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIWK ACPRK ACUHS AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 E3Z EBD EMOBN ESX FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE HZ~ I09 IHR IPNFZ KQ8 LK8 M1P MODMG O-U O9- OK1 P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RIG RPM SV3 TR2 TUS UKHRP ~8M 3V. ABJCF BBNVY BHPHI CGR CUY CVF ECM EIF HCIFZ KB. M7P M~E NPM PDBOC 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c493t-c069708b20e3e7603fb4d19300796b15f4ecf5402ca455c52ed1d09e3640f7473 |
IEDL.DBID | 7X7 |
ISSN | 1420-3049 |
IngestDate | Wed Aug 27 01:29:33 EDT 2025 Thu Aug 21 14:08:18 EDT 2025 Fri Jul 11 08:30:53 EDT 2025 Fri Jul 25 19:59:00 EDT 2025 Wed Feb 19 02:43:46 EST 2025 Thu Apr 24 23:08:45 EDT 2025 Tue Jul 01 03:11:47 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Tdp1 inhibitor amide ursodeoxycholic acid virtual screening molecular modelling tumor cancer deoxycholic acid chenodeoxycholic acid |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c493t-c069708b20e3e7603fb4d19300796b15f4ecf5402ca455c52ed1d09e3640f7473 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-4174-9512 0000-0002-4083-9324 |
OpenAccessLink | https://www.proquest.com/docview/2108551814?pq-origsite=%requestingapplication% |
PMID | 29562592 |
PQID | 2108551814 |
PQPubID | 2032355 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_f46633b236824cb1b5ea7adeeedc3345 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6017735 proquest_miscellaneous_2017056275 proquest_journals_2108551814 pubmed_primary_29562592 crossref_citationtrail_10_3390_molecules23030679 crossref_primary_10_3390_molecules23030679 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20180317 |
PublicationDateYYYYMMDD | 2018-03-17 |
PublicationDate_xml | – month: 3 year: 2018 text: 20180317 day: 17 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2018 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Nguyen (ref_26) 2015; 58 Wang (ref_27) 2017; 60 Popadyuk (ref_37) 2017; 86 Korb (ref_52) 2009; 49 Sharma (ref_38) 2011; 18 ref_54 Katyalm (ref_13) 2009; 8 Hofmann (ref_33) 2014; 55 Zakharenko (ref_29) 2016; 79 Mooij (ref_53) 2005; 61 Brossard (ref_41) 2014; 86 Alagoz (ref_19) 2014; 42 Borda (ref_12) 2015; 781 Jones (ref_49) 1997; 267 Katyal (ref_15) 2007; 26 Zakharenko (ref_25) 2015; 9 Zhu (ref_40) 2012; 31 Mosmann (ref_44) 1983; 65 Beretta (ref_6) 2010; 17 Zuma (ref_21) 2009; 461 Russell (ref_34) 2003; 72 Comeaux (ref_22) 2014; 46 Li (ref_36) 2014; 19 Kawale (ref_10) 2018; 46 Eldridge (ref_50) 1997; 11 Davies (ref_32) 2002; 324 ref_35 Pommier (ref_8) 2006; 6 Antony (ref_23) 2007; 35 Barthelmes (ref_17) 2004; 279 Jdey (ref_4) 2017; 23 Murai (ref_20) 2012; 287 Huang (ref_5) 2011; 21 Dexheimer (ref_24) 2009; 52 Lebedeva (ref_43) 2011; 585 Davis (ref_39) 2007; 12 Khomenko (ref_28) 2016; 24 Berman (ref_45) 2000; 28 Berman (ref_46) 2003; 10 ref_47 Lu (ref_1) 2017; 5 Nivens (ref_18) 2004; 53 Das (ref_14) 2009; 28 Dexheimer (ref_2) 2008; 8 Hirano (ref_16) 2007; 26 Allinger (ref_48) 1977; 99 Pommier (ref_9) 2010; 17 Interthal (ref_42) 2001; 98 Davies (ref_31) 2003; 10 Nguyen (ref_11) 2012; 55 Ponomarev (ref_30) 2018; 76 Laev (ref_3) 2016; 24 ref_7 Baxter (ref_51) 1998; 33 |
References_xml | – volume: 46 start-page: 494 year: 2014 ident: ref_22 article-title: Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target publication-title: Drug Metab. Rev. doi: 10.3109/03602532.2014.971957 – volume: 76 start-page: 392 year: 2018 ident: ref_30 article-title: Aminoadamantanes Containing Monoterpene-derived Fragments as Potent Tyrosyl-DNA phosphodiesterase 1 Inhibitors publication-title: Bioorg. Chem. doi: 10.1016/j.bioorg.2017.12.005 – volume: 18 start-page: 4029 year: 2011 ident: ref_38 article-title: Advances in bile acid medicinal chemistry publication-title: Curr. Med. Chem. doi: 10.2174/092986711796957266 – volume: 6 start-page: 789 year: 2006 ident: ref_8 article-title: Topoisomerase I inhibitors: Camptothecins and beyond publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1977 – volume: 26 start-page: 4732 year: 2007 ident: ref_16 article-title: Spinocerebellar ataxia with axonal neuropathy: Consequence of a Tdp1 recessive neomorphic mutation publication-title: EMBO J. doi: 10.1038/sj.emboj.7601885 – volume: 98 start-page: 12009 year: 2001 ident: ref_42 article-title: The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.211429198 – volume: 781 start-page: 37 year: 2015 ident: ref_12 article-title: Tyrosyl-DNA-phosphodiesterase I (TDP1) participates in the removal and repair of stabilized-Top2α cleavage complexes in human cells publication-title: Mutat. Res. doi: 10.1016/j.mrfmmm.2015.09.003 – volume: 9 start-page: 2044 year: 2015 ident: ref_25 article-title: Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2015.03.020 – volume: 17 start-page: 421 year: 2010 ident: ref_9 article-title: DNA topoisomerases and their poisoning by anticancer and antibacterial drugs publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2010.04.012 – volume: 31 start-page: 847 year: 2012 ident: ref_40 article-title: Wine Compounds as a Source for HTS Screening Collections. A Feasibility Study publication-title: Mol. Inf. doi: 10.1002/minf.201200103 – volume: 33 start-page: 367 year: 1998 ident: ref_51 article-title: Flexible Docking Using Tabu Search and an Empirical Estimate of Binding Affinity publication-title: Proteins Struct. Funct. Bioinform. doi: 10.1002/(SICI)1097-0134(19981115)33:3<367::AID-PROT6>3.0.CO;2-W – volume: 42 start-page: 3089 year: 2014 ident: ref_19 article-title: TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkt1260 – volume: 17 start-page: 1500 year: 2010 ident: ref_6 article-title: Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment publication-title: Curr. Med. Chem. doi: 10.2174/092986710790979971 – volume: 21 start-page: 1285 year: 2011 ident: ref_5 article-title: Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) inhibitors publication-title: Expert Opin. Ther. Pat. doi: 10.1517/13543776.2011.604314 – volume: 55 start-page: 4457 year: 2012 ident: ref_11 article-title: Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors publication-title: J. Med. Chem. doi: 10.1021/jm300335n – volume: 23 start-page: 1001 year: 2017 ident: ref_4 article-title: Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-1193 – volume: 287 start-page: 12848 year: 2012 ident: ref_20 article-title: Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.333963 – volume: 8 start-page: 760 year: 2009 ident: ref_13 article-title: Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin publication-title: DNA Repair doi: 10.1016/j.dnarep.2009.02.002 – volume: 86 start-page: 388 year: 2017 ident: ref_37 article-title: Modern approaches to modification of bile acids for the synthesis of compounds possessing valuable physicochemical and biological properties publication-title: Russ. Chem. Rev. doi: 10.1070/RCR4683 – volume: 10 start-page: 980 year: 2003 ident: ref_46 article-title: Announcing the worldwide Protein Data Bank publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/nsb1203-980 – volume: 58 start-page: 3188 year: 2015 ident: ref_26 article-title: Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b00136 – ident: ref_35 doi: 10.3390/molecules22101710 – volume: 60 start-page: 3275 year: 2017 ident: ref_27 article-title: Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl-DNA phosphodiesterase 1 (Tdp1), and tyrosyl-DNA phosphodiesterase 2 (Tdp2) publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b01565 – volume: 24 start-page: 5573 year: 2016 ident: ref_28 article-title: New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2016.09.016 – volume: 324 start-page: 917 year: 2002 ident: ref_32 article-title: Insights into Substrate Binding and Catalytic Mechanism of Human Tyrosyl-DNA Phosphodiesterase (Tdp1) from Vanadate and Tungstate-inhibited Structures publication-title: J. Mol. Biol. doi: 10.1016/S0022-2836(02)01154-3 – volume: 49 start-page: 84 year: 2009 ident: ref_52 article-title: Empirical scoring functions for advanced protein-ligand docking with PLANTS publication-title: J. Chem. Inf. Model. doi: 10.1021/ci800298z – volume: 267 start-page: 727 year: 1997 ident: ref_49 article-title: Development and validation of a genetic algorithm for flexible docking publication-title: J. Mol. Biol. doi: 10.1006/jmbi.1996.0897 – volume: 72 start-page: 137 year: 2003 ident: ref_34 article-title: The enzymes, regulation, and genetics of bile acid synthesis publication-title: Annu. Rev. Biochem. doi: 10.1146/annurev.biochem.72.121801.161712 – ident: ref_47 – volume: 61 start-page: 272 year: 2005 ident: ref_53 article-title: General and targeted statistical potentials for protein-ligand interactions publication-title: Proteins Struct. Funct. Bioinform. doi: 10.1002/prot.20588 – volume: 11 start-page: 425 year: 1997 ident: ref_50 article-title: Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes publication-title: J. Comput.-Aided Mol. Des. doi: 10.1023/A:1007996124545 – volume: 65 start-page: 55 year: 1983 ident: ref_44 article-title: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays publication-title: J. Immunol. Methods doi: 10.1016/0022-1759(83)90303-4 – volume: 585 start-page: 683 year: 2011 ident: ref_43 article-title: AP-site cleavage activity of tyrosyl-DNA phosphodiesterase 1 publication-title: FEBS Lett. doi: 10.1016/j.febslet.2011.01.032 – volume: 19 start-page: 3761 year: 2014 ident: ref_36 article-title: Synthesis and Biological Activity of Some Bile Acid-Based Camptothecin Analogues publication-title: Molecules doi: 10.3390/molecules19033761 – volume: 5 start-page: e3933 year: 2017 ident: ref_1 article-title: The neuroprotective effect of nicotine in Parkinson’s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage publication-title: PeerJ doi: 10.7717/peerj.3933 – volume: 24 start-page: 5017 year: 2016 ident: ref_3 article-title: Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2016.09.045 – volume: 53 start-page: 107 year: 2004 ident: ref_18 article-title: Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase publication-title: Cancer Chemother. Pharmacol. doi: 10.1007/s00280-003-0717-6 – volume: 35 start-page: 4474 year: 2007 ident: ref_23 article-title: Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl–DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkm463 – volume: 28 start-page: 3667 year: 2009 ident: ref_14 article-title: Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK publication-title: EMBO J. doi: 10.1038/emboj.2009.302 – volume: 12 start-page: 2106 year: 2007 ident: ref_39 article-title: Bile Acid Scaffolds in Supramolecular Chemistry: The Interplay of Design and Synthesis publication-title: Molecules doi: 10.3390/12082106 – volume: 10 start-page: 139 year: 2003 ident: ref_31 article-title: Crystal Structure of a Transition State Mimic for Tdp1 Assembled from Vanadate, DNA, and a Topoisomerase I-Derived Peptide publication-title: Chem. Biol. doi: 10.1016/S1074-5521(03)00021-8 – volume: 55 start-page: 1553 year: 2014 ident: ref_33 article-title: Key discoveries in bile acid chemistry and biology and their clinical applications: History of the last eight decades publication-title: J. Lipid Res. doi: 10.1194/jlr.R049437 – volume: 461 start-page: 674 year: 2009 ident: ref_21 article-title: A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage publication-title: Nature doi: 10.1038/nature08444 – volume: 279 start-page: 55618 year: 2004 ident: ref_17 article-title: TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II publication-title: J. Biol. Chem. doi: 10.1074/jbc.M405042200 – ident: ref_54 – ident: ref_7 doi: 10.1007/s40262-017-0587-4 – volume: 46 start-page: 520 year: 2018 ident: ref_10 article-title: Tyrosyl-DNA phosphodiesterases: Rescuing the genome from the risks of relaxation publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkx1219 – volume: 52 start-page: 7122 year: 2009 ident: ref_24 article-title: 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and related novel steroid derivatives as tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors publication-title: J. Med. Chem. doi: 10.1021/jm901061s – volume: 8 start-page: 381 year: 2008 ident: ref_2 article-title: Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy publication-title: Anticancer Agents Med. Chem. doi: 10.2174/187152008784220357 – volume: 99 start-page: 8127 year: 1977 ident: ref_48 article-title: Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00467a001 – volume: 26 start-page: 4720 year: 2007 ident: ref_15 article-title: TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo publication-title: EMBO J. doi: 10.1038/sj.emboj.7601869 – volume: 86 start-page: 279 year: 2014 ident: ref_41 article-title: Synthesis and biological evaluation of bile carboxamide derivatives with pro-apoptotic effect on human colon adenocarcinoma cell lines publication-title: Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2014.07.080 – volume: 79 start-page: 2961 year: 2016 ident: ref_29 article-title: Tyrosyl-DNA phosphodiesterase 1 inhibitors: Usnic acid enamines enhance the cytotoxic effect of camptothecin publication-title: J. Nat. Prod. doi: 10.1021/acs.jnatprod.6b00979 – volume: 28 start-page: 235 year: 2000 ident: ref_45 article-title: The Protein Data Bank publication-title: Nucleic Acids Res. doi: 10.1093/nar/28.1.235 |
SSID | ssj0021415 |
Score | 2.3387861 |
Snippet | An Important task in the treatment of oncological and neurodegenerative diseases is the search for new inhibitors of DNA repair system enzymes. Tyrosyl-DNA... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 679 |
SubjectTerms | amide Bile Bile Acids and Salts - chemical synthesis Bile Acids and Salts - chemistry Bile Acids and Salts - pharmacology Binding Sites cancer chenodeoxycholic acid deoxycholic acid Deoxyribonucleic acid DNA DNA repair Drug Evaluation, Preclinical Enzymes HCT116 Cells Humans MCF-7 Cells Molecular Docking Simulation molecular modelling Niacinamide - analogs & derivatives Niacinamide - chemical synthesis Niacinamide - chemistry Niacinamide - pharmacology Phosphodiesterase Inhibitors - chemical synthesis Phosphodiesterase Inhibitors - chemistry Phosphodiesterase Inhibitors - pharmacology Phosphoric Diester Hydrolases - metabolism Tdp1 inhibitor Tryptamines - chemical synthesis Tryptamines - chemistry Tryptamines - pharmacology tumor ursodeoxycholic acid virtual screening |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEF-kL_oifhutsoJPQugm-5Hk8dpaquAh2ELfwn7McgdnUsy1cP-9M5vc0VPRF193N2EyM5v5DbvzG8beixiFFtbmIRZNrqw2uUM_yoNqZK1q6jtKtcNf5ub8Un2-0ld3Wn3RnbCRHnhU3FFUGBOlK6WpS-Vd4TTYygbAf7uXUiX2Uox522RqSrUKjEvjGabEpP7o-9hqFgYE3ISRm70olMj6_4Qwf70oeSfynD1iDyfIyGejqI_ZPeiesPsn205tTxnM-1tY8W80sOkQ0eFCfoqudZtYvQfeR36Mu5_P_DIM3A585CzGOX6xQQE3q_x0PuNfF_1wvejpXiHVJQ_AC_6pWyzdklryPGOXZx8vTs7zqX1C7lHR69wL01SidqUACZURMjoVEK8hKmiMK3RU4CMCttJbpbXXJYQiiAakUSJiliGfs4Ou7-Al49YI8A5fQ6k0aNPUTgcVtKPKWsRkGRNbdbZ-4hanFherFnMMskD7mwUy9mH3yPVIrPG3xcdko91C4sROA-gp7eQp7b88JWOHWwu300Yd2pKqLzTCHJWxd7tpNBedm9gO-htckziHiM45Yy9Gh9hJUjYpg0QNVHuusifq_ky3XCQab0yFq0rqV__j216zByhlKpYsqkN2sP5xA28QLa3d27QxfgI2xhXQ priority: 102 providerName: Directory of Open Access Journals |
Title | Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29562592 https://www.proquest.com/docview/2108551814 https://www.proquest.com/docview/2017056275 https://pubmed.ncbi.nlm.nih.gov/PMC6017735 https://doaj.org/article/f46633b236824cb1b5ea7adeeedc3345 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdge4AXxDcZozIST0jRnPgjyRNqt5WBRDXBJvUt8ldopZJ0Szep_z13TtpRQHvJg-0kJ9_Z_p19_h0hH1hVMcm0jl2VFLHQUsUG7Ch2ouC5yDHvKN4d_jZRZ5fi61RO-w23tg-r3MyJYaJ2jcU98qMUw-QlrEfi0_IqxqxReLrap9B4SPaRugxDurLpncOVwOrUnWRycO2PfnUJZ30LsBuRcrGzFgXK_v_hzL_DJf9Yf8ZPyZMeONJhp-ln5IGvn5NHx5t8bS-InzS3fkF_YMG6BlwHDekJGNht4PZuaVPREcwBdGjnrqW6pR1zMdTRizUIuF7EJ5MhPZ817XLWYHQh3k5uPU3ol3o2N3NMzPOSXI5PL47P4j6JQmyhu1exZarIWG5S5rnPFOOVEQ5QG2CDQplEVsLbCmBbarWQ0srUu8SxwnMlWAW-Bn9F9uqm9m8I1Yp5a-Az6FB7qYrcSCecNHi_FpBZRNimO0vbM4xjootFCZ4GaqD8RwMR-bh9ZdnRa9zXeIQ62jZEZuxQ0Fz_LPuBVlYCMBQ3KVd5KqxJjPQ6084DFrCcCxmRw42Gy364tuWdcUXk_bYa1IWnJ7r2zQ20CcxDSOockdedQWwlSYvgR0IPZDumsiPqbk09nwUyb3CIs4zLg_vFeksew__DZcgkOyR7q-sb_w7Q0MoMgsnDMx9_HpD90enk_Psg7Cz8BojsD_A |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-N8TBeEN9kDDASvCBFc2I7Hw8IdSulZVuFRCftLcSOQyuVpFu6of5T_I3c5aNQQHvba-w4J9_Z97vYdz-A1zzPueJp6ma5F7syVYGr0Y7cTMYikhHxjlLu8Mk4GJ7KT2fqbAt-drkwdK2y2xPrjTorDf0j3_fpmrxCfyTfL85dYo2i09WOQqMxiyO7-oEhW_Vu1Ef9vvH9wYfJ4dBtWQVcg99fuoYHccgj7XMrbBhwkWuZIYxBZxkH2lO5tCZHHOObVCpllG8zL-OxFYHkOYJvgePegttSiJhWVDT4uA7wPPSGzckpNvL97w3Bra0Q5hMyjzd8X00R8D9c-_f1zD_83eAe3G2BKus1lnUftmzxAHYOO364h2DH5ZWdsy_0YFUgjsSOrI8GfVXXEq9YmbMD3HNYz8yyiqUVayolYxubrFDA1dztj3vs87SsFtOSbjNSNnRlmcdGxXSmZ0QE9AhOb2R6H8N2URb2KbA04NZoHIYCeKuCONIqk5nSlM-LSNAB3k1nYtqK5kSsMU8wsiENJP9owIG361cWTTmP6zofkI7WHakSd_2gvPiWtAs7ySViNqF9EUS-NNrTyqZhmlnEHkYIqRzY6zSctNtDlfw2ZgderZtRXXRakxa2vMQ-daUjKiLtwJPGINaS-HEdt-IMhBumsiHqZksxm9bFwzEAD0Ohdq8X6yXsDCcnx8nxaHz0DO6gLHUiphfuwfby4tI-RyS21C9q82fw9abX2y-u0Eeb |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxLO4FFgkuCBZWXt3_TgglDZEDYWoEq2Um_G-SKRgp3ValL_Gr2PGj5QA6q1X79oa7czufOOdmY-QN8w5Jlme-8YFqS9yGfkK7Mg3IuWJSJB3FGuHv4yjw1PxaSInW-RXVwuDaZXdmVgf1KbU-I-8F2KavAR_JHquTYs4Hgw_LM58ZJDCm9aOTqMxkSO7-gnhW_V-NABdvw3D4ceTg0O_ZRjwNciy9DWL0pglKmSW2zhi3ClhANKA40wjFUgnrHaAaUKdCym1DK0JDEstjwRzAMQ5fPcWuR1zGeAeiydXwV4AnrG5ReU8Zb0fDdmtrQDyI0pPN_xgTRfwP4z7d6rmH75v-IDcb0Er7TdW9pBs2eIRuXvQccU9JnZcXto5_YoPVgVgSphIB2Dcl3Vf8YqWju7D-UP7emYqmle06ZoMY_RkBQKu5v5g3KfH07JaTEvMbMTK6MrSgI6K6UzNkBToCTm9keV9SraLsrDPCM0jZrWCz2Awb2WUJkoaYaTC2l5AhR5h3XJmuu1ujiQb8wyiHNRA9o8GPPJu_cqiae1x3eR91NF6Inblrh-U59-zdpNnTgB-4yrkURIKrQIlbR7nxgIO0ZwL6ZG9TsNZe1RU2ZVhe-T1ehjUhTc3eWHLC5hTdz3ChtIe2WkMYi1JmNYxLKxAvGEqG6JujhSzad1IHILxGGx393qxXpE7sNOyz6Px0XNyD0SpazKDeI9sL88v7AsAZUv1srZ-Sr7d9Hb7DaT1S8g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+Semisynthetic+Derivatives+of+Bile+Acids+as+Effective+Tyrosyl-DNA+Phosphodiesterase+1+Inhibitors&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Salomatina%2C+Oksana&rft.au=Popadyuk%2C+Irina&rft.au=Zakharenko%2C+Alexandra&rft.au=Zakharova%2C+Olga&rft.date=2018-03-17&rft.issn=1420-3049&rft.eissn=1420-3049&rft.volume=23&rft.issue=3&rft.spage=679&rft_id=info:doi/10.3390%2Fmolecules23030679&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_molecules23030679 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |